The strategies of drug supply for patients with chronic hepatitis C

QR Code

The strategies of drug supply for patients with chronic hepatitis C

The report reviews the options of drug supply for patients with chronic hepatitis C in the Russian Federation and elsewhere. The results of the Moscow regional program aimed at improving the quality of medical care in such patients are discussed. The proposed measures contribute to the reduced morta...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. V. Kornilova, A. D. Ermolaeva, M. G. Rusanova, D. A. Andreev, M. V. Davydovskaya, T. N. Ermolaeva, A. g Pokatilo, K. I. Polyakova, V. A. Dubovtseva, K. А. Kokushkin, A. V. Devyatkin
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2017-11-01
Series:	Фармакоэкономика
Subjects:	chronic hepatitis c antiviral therapy innovative model of drug supply risk-sharing scheme drug supply hcv infection pilot project
Online Access:	https://www.pharmacoeconomics.ru/jour/article/view/211
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Combined use of direct antiviral drugs - paritrapevir, ritonavir, ombitasvir and dasabuvir in the treatment of patients with HCV-deterministic compensated cirrhosis in real clinical practice
by: Yu. M. Ambalov, et al.
Published: (2018-06-01)

Drug resistant variants of hepatitis C virus genotype 1b in Russia: analysis of aminoacid substitutions in NS5a and core proteins
by: V. S. Kichatova, et al.
Published: (2018-12-01)

Clinical Practice Guidelines of the Russian Society for the Study of the Liver, the Russian Gastroenterological Association, the National Scientific Society of Infectious Disease Specialists for the Diagnosis and Treatment of Chronic Hepatitis C
by: V. T. Ivashkin, et al.
Published: (2023-06-01)

Issues of National Drug Security in Formation of a Reserve of Antibacterial Agents Intended to Eliminate Medical and Sanitary Consequences of Emergencies
by: L. Yu. Chernikova, et al.
Published: (2022-09-01)

Interactions between Immunosuppressive Therapy and Direct-Acting Antivirals in Kidney Transplant Recipient with Hepatitis C Infection
by: Paolo Carta, et al.
Published: (2020-05-01)

The use of essential drugs : reports /
by: WHO Expert Committee
Published: (1983)

Medical care payment improvement within diagnosis-related groups of patients with severe asthma requiring biologic disease-modifying drugs by regional adaptation mechanism in the Moscow Region
by: A. D. Ermolaeva, et al.
Published: (2021-07-01)

CORRIGENDUM: Problems and Solutions of Pharmaceutical Packaging in Bulk [Pharmacy & Pharmacology. 2025;13(2):128-138. DOI: 10.19163/2307-9266-2025-13-2-128-138]
by: R. Yu. Garankina, et al.
Published: (2025-08-01)

Problems and Solutions of Pharmaceutical Packaging in Bulk
by: R. Yu. Garankina, et al.
Published: (2025-07-01)

The prevalence of the hepatitis C virus among the conditionally healthy population of the Russian Federation
by: N. V. Soboleva, et al.
Published: (2017-06-01)

RESTRICTIVE LISTS OF DRUGS: REGULATIONS, FUNCTIONS, SOURCES OF FINANCE, AND GUIDELINES FOR CREATION
by: M. V. Sura
Published: (2017-05-01)

PROSPECTS OF IMPROVING TREATMENT OF HSV INFECTED AT THE DENTIST’S
by: E. V. Nikolishyna, et al.
Published: (2018-03-01)

Drug-induced lesion of the liver: general-purpose morphological markers
by: V. T. Ivashkin, et al.
Published: (2009-03-01)

Herbal medications in the treatment of hepatitis C
by: V. T. Ivashkin, et al.
Published: (2009-06-01)

TREATMENT OF HEPATITIS C WITHOUT INTERFERON IN PATIENTS UNDERGOING LIVER TRANSPLANTATION
by: M. Sh. Khubutia, et al.
Published: (2015-10-01)

Justification of the program therapy of acute hepatitis C
by: E. A. Mikhailova, et al.
Published: (2014-09-01)

The Four Towns Water Supply Scheme /
by: Bridges, G.
Published: (1983)

Organization of Medical Care and Drug Supply for Patients with Osteogenesis Imperfecta in the Republic of Bashkortostan
by: A. A. Bakirov, et al.
Published: (2016-12-01)

Dynamic changes in the prevalence of markers of hepatitis C virus infection among the conditionally healthy population of the Tyva Republic
by: A. A. Saryglar, et al.
Published: (2024-01-01)

ORGANIZATION OF PREFERENTIAL DRUG SUPPLY FOR PATIENTS WITH EPILEPSY IN KRASNOYARSK REGION
by: E. N. Bochanova, et al.
Published: (2016-05-01)

THE PROBLEMS OF BENEFICIAL DRUG SUPPORT
by: L. V. Shukil, et al.
Published: (2015-09-01)

Efficacy and Safety of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients: Real-World Data
by: Muhammet Rıdvan Tayşi, et al.
Published: (2025-07-01)

Clinical and economic analysis as an instrument for harmonizing import substitution in the preferential segment of medicinal support
by: E. V. Eliseeva, et al.
Published: (2019-10-01)

Accounting power supply schemes for traction substations in the calculation of short circuits in the AC traction network
by: Yu. I. Zharkov, et al.
Published: (2019-05-01)

CORRIGENDUM: Regulation in the sphere of circulation of extemporaneously compounded medicines under modern conditions of Russia [. Pharmacy & Pharmacology. 2024;12(5):324-337. DOI: 10.19163/10.19163/2307-9266-2024-12-5-324-337]
by: V. V. Ryazhenov, et al.
Published: (2025-08-01)

Regulation in the sphere of circulation of extemporaneously compounded medicines under modern conditions of Russia
by: V. V. Ryazhenov, et al.
Published: (2025-06-01)

Prevalence of Hepatitis C in the Emilia-Romagna Region of Italy: Population-Wide Screening
by: Gianmarco Imperiali, et al.
Published: (2025-06-01)

Direct-Acting-Antivirals Anti-hepatitis C Virus in Renal Transplant Patients: Relevance of Pharmacologic Interaction
by: Maurizio Salvadori, et al.
Published: (2020-08-01)

ROAD MAP FOR DEVELOPMENT OF PRICE REGULATION SYSTEM AND SYSTEM OF DRUG SUPPLY AT THE EXPENSE OF RUSSIAN FEDERATION HEALTHCARE SYSTEM FUNDS
by: M. V. Sura, et al.
Published: (2015-05-01)

Cryoglobulinemia and hepatitis C virus
by: N. V. Dunaeva, et al.
Published: (2014-09-01)

SOME ASPECTS OF THE MARKETING STUDIES FOR THE PHARMACEUTICAL MARKET OF ANTIVIRAL DRUGS
by: A. G. Salnikova, et al.
Published: (2015-12-01)

IDENTIFICATION OF RESERVES TO INCREASE THE EFFECTIVENESS OF PHARMACEUTICAL COUNSELING FOR THE POPULATION
by: E. E. Chupandina, et al.
Published: (2017-12-01)

Problems and potential solutions to drug shortages
by: I. R. Svechkareva, et al.
Published: (2024-09-01)

Treatment of the chronic hepatitis C complicated by mixed cryoglobulinemia with direct-acting antiviral agents
by: N. V. Dunaeva, et al.
Published: (2018-12-01)

Advancing Viral Defense: Unravelling the Potential of Host-Directed Antivirals Against SARS-CoV-2
by: Zheng Yao Low, et al.
Published: (2025-03-01)

Treatment of patients with malignant lymphoproliferative diseases in the Russian Federation: analysis of the data from 75 regions
by: G. R. Hachatryan, et al.
Published: (2019-01-01)

Experimental Justification of Reprofiling of the Drug Maxar® for the Treatment of Viral Infections
by: T. S. Zaporozhets, et al.
Published: (2023-10-01)

Study of the Antiviral Activity of Drugs and Their Combination Against the Influenza A Virus
by: E. N. Vetrova, et al.
Published: (2025-02-01)

Ribavirin and its analogs: Сan you teach an old dog new tricks?
by: M. V. Chudinov
Published: (2019-08-01)

LIPID INFILTRATION OF HEPATOCYTES IN THE MORPHOGENESIS OF CHRONIC HEPATITIS C
by: D. L. Nepomnyashchikh, et al.
Published: (2019-09-01)